Meeting
2011 ASCO Annual Meeting
Mutations of EGFR, K-ras, and EML-4ALK genes in resected lung adenocarcinoma and their clinical significance.
Authors
T. Ohba
National Kyushu Cancer Center, Fukuoka, Japan
T. Ohba , K. Sugio , T. Kometani , M. Yamaguchi , M. Hamatake , K. Nosaki , H. Takeoka , H. Kitajima , F. Hirai , T. Seto , Y. Ichinose
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Local-regional and Adjuvant Therapy/Small Cell
Track
Lung Cancer
Sub Track
Local-Regional Therapy
Citation
J Clin Oncol 29: 2011 (suppl; abstr 7033)
Abstract #
7033
Poster Bd #
20E
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Natural history of curatively resected stage IB-IIIA EGFR mutation (+) NSCLC: Clinicopathologic and molecular prognostic factors (ROOT-EGFR-ADJ).
First Author: Hyun Ae Jung
Poster
2020 ASCO Virtual Scientific Program
Circulating tumor DNA dynamics to predict cancer recurrence/metastasis in Chinese pathologic stage I lung adenocarcinoma.
First Author: Chao Cheng
Poster
2015 ASCO Annual Meeting
The impact of a Bim deletion polymorphism on the survival of patients with completely resected non-small cell lung cancer.
First Author: Jun Atsumi
Poster
2013 ASCO Annual Meeting
Frequency of oncogenic alterations in five driver genes in Chinese female lung adenocarcinoma.
First Author: Ren Xu